112628 ⎘
Measuring or testing processes involving enzymes, nucleic acids or microorganisms ; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
Sub-classes:METHODS FOR ANALYZING VIRAL NUCLEIC ACID
#2METAGENOMIC DATA FILTERING FOR HEALTH DIAGNOSTICS, FOOD QUALITY AND SAFETY, AND SURROUNDING ENVIRONMENTAL SAFETY
#3Self-Contained Apparatus and System for Detecting Microorganisms
#4METHODS AND SYSTEMS FOR PROCESSING A NUCLEIC ACID SAMPLE
#5METHOD FOR CONCENTRATING PATHOGENS OR NUCLEIC ACID USING ACID ACTIVATED BENTONITE
#6CHARACTERIZATION OF IMPURITIES IN ADENO-ASSOCIATED VIRUS (AAV) SAMPLES AND FORMULATION COMPOSITIONS TO STABILIZE AAV
#7Methods for Diagnosing Infectious Disease and Determining HLA Status Using Immune Repertoire Sequencing
#8METHODS FOR QUANTITATING VIRAL CAPSIDS
#9ELECTRONIC TEST RESULT DETERMINATION AND CONFIRMATION
#10Methods for Treating a Health Condition with Probiotics
#11VIRUS NUCLEIC ACID SAMPLE DILUENT, VIRUS NUCLEIC ACID SAMPLE EXTRACTION KIT, AND VIRUS NUCLEIC ACID EXTRACTION METHOD
#12IMMUNOASSAY FOR SARS-CoV-2 ANTIBODIES
#13LOWER RESPIRATORY TRACT INFECTIONS
#14COMPOSITION FOR DETECTING TARGET NUCLEIC ACID AND USE THEREOF
#15SYSTEMS AND METHODS FOR IDENTIFYING VIRAL CONTAMINANTS
#16PSEUDOVIRUS BASED NEUTRALIZATION ASSAY FOR EVALUATING VACCINE IMMUNOGENICITY
#17VIRUS DETECTION VIA PROGRAMABLE TYPE III-A CRISPR-CAS SYSTEMS AND METHODS
#18SYSTEMS AND METHODS FOR ULTRA-SPECIFIC AND ULTRA-SENSITIVE NUCLEIC ACID DETECTION
#19DIAGNOSTIC COMPLEX, RAPID POINT-OF-CARE DIAGNOSTIC KIT USING SAME, AND DIAGNOSTIC METHOD
#20METHOD OF RAPID EXTRACTION OF DNA FROM SALIVA AND QPCR AMPLIFICATION OF GROUP A STREPTOCOCCUS DNA
#21METHODS FOR DETECTING AND TREATING HEAD AND NECK CANCER
#22INFECTIOUS FULL-LENGTH CLONE OF ZIKA VIRUS OR VARIANT THEREOF AND USE THEREOF
#23METHODS AND KITS FOR ISOLATING CELL-FREE DNA OR CIRCULATING FETAL DNA FROM URINE SAMPLES
#24CO-BINDER ASSISTED ASSAY METHODS
#25METHODS TO OBTAIN A BIOLOGICAL SAMPLE REPRESENTATIVE OF A PASSENGER CABIN ON AN AIRCRAFT AUTOMATICALLY FROM THE COLLECTOR DEVICE
#26ANALYZING RNA FOR DIAGNOSING INFECTION TYPE
#27METHOD FOR CONSTRUCTING HOTSPOT-DERIVED PEPTIDE-NUCLEIC ACID HYBRID MOLECULES ON BASIS OF IN VITRO SELECTION
#28COMPOSITION FOR PRETREATMENT AND METHOD FOR PRETREATMENT OF TARGET SAMPLE OF NUCLEIC ACID DETECTION
#29MEASUREMENT DEVICE, MEASUREMENT METHOD, AND PROGRAM
#30QUALITATIVE AND QUANTITATIVE DETERMINATION OF SINGLE VIRUS HAPLOTYPES IN COMPLEX SAMPLES
#31Heteromultivalent DNA-Functionalized Materials to Detect Genetic Mutations and Use in Diagnostic Applications
#32METHODS FOR QUANTITATION OF NUCLEIC ACID TARGETS
#33PROBE DESIGN FOR DETECTION OF ONCOGENIC VIRUSES
#34SYSTEMS AND METHODS FOR ANALYZING VIRAL NUCLEIC ACIDS
#35METHODS AND SYSTEMS FOR ANALYSIS OF SAMPLES CONTAINING PARTICLES USED FOR GENE DELIVERY
#36INSECT CELLS AND METHODS FOR ENGINEERING THE SAME
#37METHODS FOR THE TRANSLATED ALIGNMENT OF TRANSCRIPTOMIC DATA AT SINGLE-CELL RESOLUTION
#38MULTIPLEX CARTRIDGE FOR DETECTION OF VIRAL AND/OR BACTERIAL NUCLEIC ACIDS AND HUMAN OR ANIMAL SINGLE NUCLEOTIDE POLYMORPHISMS
#39SYSTEMS AND METHODS OF NOVEL CRISPR-CAS PROTEINS FOR IN-VITRO APPLICATIONS
#40HYDROPHOBIC INTERACTION CHROMATOGRAPHY FOR VIRAL CLEARANCE
#41IMPROVED METHODS AND DEVICES FOR ACCURATE DIAGNOSIS OF INFECTIONS
#42ENHANCEMENT OF CANCER SCREENING USING CELL-FREE VIRAL NUCLEIC ACIDS
#43IN VITRO CO-CULTURE ALVEOLUS-CAPILLARY MODEL SYSTEM FOR STUDYING ACUTE LUNG INJURY INDUCED BY RESPIRATORY VIRUS INFECTIONS
#44MITOCHONDRIAL NUCLEIC ACID DEPLETION AND DETECTION
#45AIRCRAFT GALLEY INSERT WITH PATHOGENS DIAGNOSTIC TEST CAPABILITIES
#46RIBOZYME-ASSISTED CIRCULAR RNAS AND COMPOSITIONS AND METHODS OF USE THEREOF
#47MOLECULAR SIGNATURES FOR CELL TYPING AND MONITORING IMMUNE HEALTH
#48IMPROVED ISOTHERMAL AMPLIFICATION
#49METHODS AND KITS USEFUL FOR DIAGNOSIS OF UROGENITAL CANCER
#50Methods and kits useful for diagnosis of human papillomavirus (HPV)
#51MODIFIED U6 PROMOTER SYSTEM FOR TISSUE SPECIFIC EXPRESSION
#52COMPOSITIONS AND METHODS FOR HIV QUASI-SPECIES EXCISION FROM HIV-1-INFECTED PATIENTS
#53METHODS FOR ISOLATING TARGET ANALYTES FROM URINE SAMPLES USING ATPS AND MAGNETIC BEADS
#54METHOD FOR PREDICTING RELATIONSHIP BETWEEN BACTERIOPHAGE AND BACTERIAL INFECTION
#55METHOD OF ASSESSING RISK OF PML
#56METHODS OF IDENTIFYING CANCER-ASSOCIATED MICROBIAL BIOMARKERS
#57COMPOSITIONS, DEVICES AND METHODS FOR AN IMPROVED RAPID POINT-OF-USE DIAGNOSTIC ASSAY
#58METHOD FOR SCREENING FOR MODIFICATIONS IN THE INFECTIVITY RANGE OF BACTERIOPHAGES DUE TO EPIGENETIC IMPRINTING
#59METHOD FOR RAPIDLY AND ACCURATELY DETECTING HOP LATENT VIROID RNA
#60METHOD AND KIT FOR RAPIDLY DETECTING VIRAL GENOME SIZE
#61METHODS AND SYSTEMS FOR PROCESSING A NUCLEIC ACID SAMPLE
#62Subgenomic RNAs for Evaluating Viral Infection
#63METHODS AND SYSTEMS FOR PROCESSING A NUCLEIC ACID SAMPLE
#64COMPOSITIONS AND SYSTEMS FOR RNA-PROGRAMMABLE CELL EDITING AND METHODS OF MAKING AND USING SAME
#65BLOOD CELL LYSIS REAGENT
#66MEANS AND METHODS FOR DIAGNOSING A VIRAL INFECTION OR A DISEASE ASSOCIATED THEREWITH
#67HIGH-THROUGHPUT SCREENING OF SARS-COV-2 VARIANTS
#68METHODS FOR MEASURING AND VISUALIZING ALU RNA
#69METHOD FOR DETECTING A PHAGE OR ANTIBIOTIC SENSITIVITY WITH RESPECT TO A BACTERIAL STRAIN
#70A SYSTEM AND METHOD FOR MONITORING THE EFFECT OF A HERPESVIRUS-BASED VACCINE IN AN ANIMAL POPULATION
#71MICROBIAL BIOMARKERS IN TRANSPLANTATION AND RELATED METHODS
#72A MICROFLUIDIC PIPELINE FOR ISOLATION AND ANALYSIS OF SINGLE VIRUSES
#73METHODS AND COMPOSITIONS FOR ANALYZING NUCLEIC ACIDS AND NUCLEASES IN A BODY FLUID AS INDICATORS OF DISEASE
#74NUCLEASES FOR SIGNAL AMPLIFICATION
#75METHODS OF TREATMENT OF HIGH-GRADE SQUAMOUS INTRAEPITHELIAL LESION (HSIL)
#76ANALYSIS OF VITREOUS SAMPLES TO GUIDE TREATMENT
#77Role of Human Pegivirus (HPGV) in Parkinson's Disease: Implications for Diagnosis and Treatment
#78APPARATUS
#79HIGH THROUGHPUT NUCLEIC ACID TESTING OF BIOLOGICAL SAMPLES
#80COMPOSITIONS, DEVICES AND METHODS FOR AN IMPROVED RAPID POINT-OF-USE DIAGNOSTIC ASSAY
#81Airborne monitor to detect SARS-CoV-2 wild-type and mutations in airborne samples using Nucleic Acid Amplification Techniques (NAT)
#82DEVELOPMENT AND VALIDATION OF A 2-GENE HOST-VIRAL TRANSCRIPTOMIC CLASSIFIER FOR ENHANCED COVID-19 DIAGNOSIS
#83BACTERIOPHAGE-BASED SERS-ACTIVE GOLD NANOHALO STRUCTURE AND MANUFACTURING METHOD THEREFOR
#84COMPOSITIONS AND METHODS FOR DETECTION OF VIRAL PATHOGENS IN SAMPLES
#85COMPOSITIONS AND METHODS FOR DETECTION OF VIRAL PATHOGENS IN SAMPLES
#86METHODS AND COMPOSITIONS FOR DETECTING SARS-COV2 VIRUS OMICRON, ALPHA, BETA, DELTA, OR GAMMA
#87SYSTEMS AND METHODS FOR DETERMINING VIRUSES SUCH AS CORONAVIRUSES
#88COMPOSITIONS AND METHODS FOR DETECTION OF VIRAL PATHOGENS IN SAMPLES
#89COMPOSITIONS AND METHODS FOR DETECTION OF VIRAL PATHOGENS IN SAMPLES
#90COMPOSITIONS AND METHODS FOR DETECTION OF VIRAL PATHOGENS IN SAMPLES
#91ISOTHERMAL GENE AMPLIFICATION METHOD, GENE DETECTION METHOD, VIRUS DETECTION METHOD, AND KIT USED THEREFOR
#92METHODS AND SYSTEMS FOR THE RAPID DETECTION OF SALMONELLA USING INFECTIOUS AGENTS
#93DROPLET DIGITAL PCR ASSAY FOR DETERMINING VIRAL VECTOR GENOMIC TITER
#94SYSTEMS AND METHODS OF DELIVERING TARGET MOLECULES TO A NANOPORE
#95ISOTHERMAL BASED-DUAL FUNCTIONAL OLIGONUCLEOTIDE INCLUDING REPORTER DYE, AND QUENCHER FOR ISOTHERMAL NUCLEIC ACID AMPLIFICATION AND MEASUREMENT METHODS USING SAME
#96COMPOSITIONS AND METHODS FOR RAPID COVID-19 DETECTION
#97METHODS TO ANALYZE HOST-MICROBIOME INTERACTIONS AT SINGLE-CELL AND ASSOCIATED GENE SIGNATURES IN CANCER
#98DIRECT AMPLIFICATION AND DETECTION OF VIRAL AND BACTERIAL PATHOGENS
#99VIRAL CLEARANCE TEST METHOD
#100CRISPR-MEDIATED CLEAVAGE OF OLIGONUCLEOTIDE-DETECTABLE MARKER CONJUGATES FOR DETECTION OF TARGET ANALYTES
#101Methods for isolating target analytes from biological samples using ATPS and solid phase media
#102SYSTEMS AND METHODS FOR DETECTING MICROORGANISM OR VIRAL LOADED AEROSOLS
#103CULTURE-FREE BIPHASIC APPROACH FOR RAPID DETECTION OF PATHOGENS FROM WHOLE BLOOD
#104SILICA-BASED CHROMATOGRAPHIC PROCESSES FOR ISOLATING NUCLEIC ACID-PROTEIN COMPLEXES AND DETECTING TARGET NUCLEIC ACIDS
#105Methods and Kits to Detect Viral Particle Heterogeneity
#106SENSITIZER FOR NUCLEIC ACID AMPLIFICATION, COMPOSITION FOR NUCLEIC ACID AMPLIFICATION, AND TEST KIT
#107ANTIBODY AND DNA OLIGO CONJUGATES AND THEIR APPLICATION IN ELISA-PCR TESTS
#108VARIANT CLASSIFICATION THROUGH HIGH-CONFIDENCE MUTATION DETECTION FROM FLUORESCENCE SIGNALS MEASURED WITH A MULTIPLE MUTATION ASSAY
#109METHOD FOR IDENTIFYING AND/OR REGULATING SENESCENCE
#110SYSTEMS AND DEVICES FOR TREATMENT BY MEANS OF TRANSFER OF INFORMATION IN WATER
#111Methods and systems for analysis of samples containing particles used for gene delivery
#112SAMPLE PRETREATMENT KIT AND METHOD FOR DETECTING VIRUS INFECTIVITY
#113METHOD FOR DETECTING TARGET BIOMOLECULE IN BIOLOGICAL SAMPLE, DISPOSABLE OPTICAL FIBER SENSOR THEREFOR, AND CARTRIDGE THEREOF
#114METHODS AND SYSTEMS FOR DETECTION OF MICROORGANISMS
#115RNA MARKERS FOR DIAGNOSING INFECTIONS
#116Loop-Mediated Synthetic Riboregulators
#117EVALUATION METHOD OF PATHOGEN INACTIVATION EFFECT
#118DIGITAL CRISPR-BASED METHOD FOR THE RAPID DETECTION AND ABSOLUTE QUANTIFICATION OF NUCLEIC ACIDS
#119Methods for Treating a Health Condition with Probiotics
#120SYSTEMS AND METHODS FOR HIGH THROUGHPUT SCREENING OF MOLECULAR INTERACTIONS
#121COMPOSITIONS, KITS AND METHODS FOR COLLECTING ANALYTE IN A SALIVA SAMPLE
#122SAMPLE PRE-TREATMENT FOR ISOTHERMAL AMPLIFICATION
#123PRIMER COMPOSITION FOR RECOMBINASE-POLYMERASE AMPLIFICATION REACTION FOR RAPID DIAGNOSIS OF ISRAELI ACUTE BEE PARALYSIS VIRUS AND USE THEREOF
#124CORONAVIRUS-INFECTIVE CELLS AND METHOD OF PREPARING SAME
#125Systems and methods for analyzing viral nucleic acids
#126MOLECULAR TRANSPORT FOR VIRAL AGENTS
#127MUCINS AND ISOFORMS THEREOF IN DISEASES CHARACTERIZED BY BARRIER DYSFUNCTION
#128METHOD OF PRODUCING MODIFIED VIRUS GENOMES AND PRODUCING MODIFIED VIRUSES
#129Infectious disease screening device
#130APPARATUS, DEVICE AND METHOD FOR PHOTODETECTION OF PATHOGENS
#131METHODS FOR ASSESSING THE SEVERITY AND PROGRESSION OF SARS-COV2 INFECTIONS USING CELL-FREE DNA
#132CRISPR-BASED METHODS FOR THE DETECTION OF NUCLEIC ACIDS IN A SAMPLE
#133Compositions and Methods for Determining Resistance to Inhibitors of Virus Enter Using Recombinant Virus Assays
#134ON-SITE VIRAL INACTIVATION AND RNA PRESERVATION OF GARGLE AND SALIVA SAMPLES COMBINED WITH DIRECT ANALYSIS OF SARS-COV-2 RNA ON MAGNETIC BEADS
#135POINT OF CARE AND IMPROVED DETECTION AND QUANTIFICATION OF BIOMOLECULES
#136NON-ANIMAL HUMAN RELEVANT WORKSTATION SYSTEM AND METHOD FOR TESTING NEUROVIRULENCE AND NEUROTOXICITY IN VACCINES
#137REAGENT AND METHOD FOR FLUORESCENCE QUANTITATIVE REAL-TIME PCR DETECTION OF RCL
#138Methods for detecting norovirus
#139APPARATUS AND METHOD FOR SAMPLING AND DETECTING A PATHOGEN IN AIR
#140MULTIPLEX CARTRIDGE FOR DETECTION OF VIRAL NUCLEIC ACIDS AND HUMAN OR ANIMAL SNPS
#141PRODUCTS AND METHODS FOR DETECTION OF VIRAL NUCLEIC ACID
#142MULTIPLEXED METHODS FOR DETECTING TARGET RNAS
#143METHOD FOR PROVIDING PREPARATION FOR DETECTING TARGET NUCLEIC ACID SEQUENCE IN SPECIMEN
#144METHOD FOR ISOLATING NUCLEIC ACID
#145KIT AND METHODS FOR CHARACTERIZING A VIRUS IN A SAMPLE
#146A CELLULAR MARKER OF COVID SEVERITY
#147TARGET RNA DETECTION METHOD BASED ON DCAS9/GRNA COMPLEX
#148GENE EDITING METHODS AND COMPOSITIONS FOR ELIMINATING RISK OF JC VIRUS ACTIVATION AND PML (PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY) DURING IMMUNOSUPPRESSIVE THERAPY
#149NOVEL CORONAVIRUS NUCLEIC ACID RAPID HYBRID CAPTURE IMMUNOFLUORESCENCE DETECTION KIT, AND PREPARATION METHOD AND DETECTION METHOD THEREOF
#150DEVICE AND METHOD FOR CAPTURING AND ANALYZING AIRBORNE ORGANISMS
#151METHODS TO DETECT AND TREAT SARS-COV-2 (COVID19) INFECTION
#152ENHANCED NUCLEIC ACID IDENTIFICATION AND DETECTION
#153Methods for detecting respiratory viral infection
#154IMMUNOTHERAPY FOR POLYOMAVIRUSES
#155VIRAL SAMPLE COLLECTION
#156METHODS TO DETECT A VIRUS IN A BIOLOGICAL SAMPLE
#157METHODS AND DEVICES FOR COVID-19 TESTING USING URINE SAMPLES
#158TARGETED THERAPY FOR THE TREATMENT & PREVENTION OF LIFE-THREATENING COMPLICATIONS OF INFECTION
#159RNA VIRUS DETECTION METHOD
#160A METHOD FOR MULTIPLEXED DETECTION OF A PLURALITY OF TARGET BIOMOLECULES
#161SINGLE STEP SAMPLE PREPARATION FOR NEXT GENERATION SEQUENCING
#162A LYOPHILIZED TEST KIT FOR DETERMINATION OF ANTIMICROBIAL BIOLOGICAL ACTIVITY OF PHAGE PREPARATIONS AGAINST THE BACTERIA STAPHYLOCOCCUS AUREUS
#163GENOME INTEGRITY ANALYSIS OF VIRUS VECTORS
#164Diagnostic control compositions
#165Methods and systems for analysis of samples containing particles used for gene delivery
#166Methods and Apparatuses for Early Diagnosis of Lung Infection Acuity
#167BACTERIAL DELIVERY VEHICLES COMPRISING TRACER NUCLEIC ACID SEQUENCES
#168PCR-Activated Sorting (PAS)
#169COLOR READING FOR DIAGNOSTIC TESTS
#170ANTIBODY-FREE RAPID DETECTION OF SARS-COV-2 PROTEINS USING CORONA PHASE MOLECULAR RECOGNITION (COPHMORE)
#171COMPOSITIONS AND METHODS FOR THE SELECTIVE DETECTION OF TUMOR-DERIVED VIRAL DNA
#172METHOD FOR EVALUATING VIRAL CLEARANCE CAPABILITY
#173Systems and methods for determining viruses such as coronaviruses
#174METHOD FOR EVALUATION OF VIABILITY OF VIRUSES WITH LYMPHOTROPISM PROPERTIES
#175Modified U6 promoter system for tissue specific expression
#176METHODS AND SYSTEMS FOR ANALYSIS OF SAMPLES CONTAINING PARTICLES USED FOR GENE DELIVERY
#177VIRUS DETECTION
#178COMPOSITION FOR DIAGNOSING SARS-COV-2, KIT, AND METHOD FOR DIAGNOSING SARS-COV-2 BY USING SAME
#179ROTATION SCHEME FOR BACTERIAL CULTURES IN FOOD PRODUCT FERMENTATION
#180RNA DETERMINANTS FOR DISTINGUISHING BETWEEN BACTERIAL AND VIRAL INFECTIONS
#181COMPOSITIONS AND METHODS RELATED TO SURGE-ASSOCIATED SARS-COV-2 MUTANTS
#182DEVICES AND METHODS FOR EXTRACTION-FREE PATHOGEN TESTING
#183LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) ON A SOLID-PHASE MEDIUM
#184COMPOSITION AND METHOD FOR IMPROVING DETECTION OF BIOMOLECULES IN BIOFLUID SAMPLES
#185METHODS AND COMPOSITIONS FOR INHIBITING POLYOMAVIRUS-ASSOCIATED PATHOLOGY
#186METHOD FOR DETECTION OF NUCLEIC ACID SEQUENCES FROM BIOLOGICAL SAMPLES OF MEDICAL, AGRICULTURAL AND BIOTECHNOLOGICAL INTEREST AND APPARATUS THEREOF
#187DROPLET COLLECTION UNIT, AND DROPLET COLLECTION APPARATUS AND METHOD
#188MAGNETIC TUNNEL JUNCTION BASED MOLECULAR SPINTRONICS DEVICE AND MAGNETIC RESONANCE SENSORS
#189Method of assessing risk of PML
#190DIAGNOSTIC TEST FOR VACCINE VALIDATION AND AUTHENTICATION AND METHODS OF USE THEREOF
#191METHODS FOR IMPROVING NUCLEIC ACID CLUSTER CLONALITY
#192Infectious disease screening system
#193VIRUS DETECTION VIA PROGRAMABLE TYPE III-A CRISPR-CAS SYSTEMS AND METHODS
#194METHODS FOR IDENTIFICATION OF ANTIGEN BINDING SPECIFICITY OF ANTIBODIES
#195SYSTEM AND METHOD FOR AIRBORNE VIRAL PATHOGEN DETECTION
#196METHODS AND REAGENTS FOR NUCLEIC ACID AMPLIFICATION AND/OR DETECTION
#197Nucleic acid probe set and nucleic acid lateral flow immunoassay having the same
#198EXOSOME-MEDIATED DIAGNOSIS OF HEPATITIS VIRUS INFECTIONS AND DISEASES
#199PCR-Activated Sorting (PAS)
#200IN VITRO METHOD FOR THE DIAGNOSIS OF VIRAL INFECTIONS
#201Bacteriophage Hydrogel Compositions and Uses Thereof
#202Compositions and methods for the selective detection of tumor-derived viral DNA
#203Assays for the Detection of SARS-CoV2 Mutants
#204EXOSOME-MEDIATED DIAGNOSIS OF HEPATITIS VIRUS INFECTIONS AND DISEASES
#205ELECTRONIC TEST RESULT DETERMINATION AND CONFIRMATION
#206COMPOSITIONS AND METHODS FOR DETECTION OF EPSTEIN BARR VIRUS (EBV)
#207METHODS OF DIAGNOSING INFECTIOUS DISEASE PATHOGENS AND THEIR DRUG SENSITIVITY
#208Adeno-Associated Virus Virions with Variant Capsid and Methods of Use Thereof
#209Infectious disease screening device
#210Methods and Systems for the Rapid Detection of Listeria Using Infectious Agents
#211RESPIRATORY DISEASE SURVEILLANCE SYSTEMS AND METHODS USING HIGH FLOWRATE AEROSOL CAPTURE FOR RAPID ON-SITE ANALYSIS
#212SURROGATE VIRUS ASSAYS AND METHODS
#213A Ribozyme Comprising a Target-Binding Domain
#214LATERAL FLOW ANALYSIS STRIP AND MOLECULAR DIAGNOSTIC METHOD USING SAME
#215METHOD OF POOLING BLOOD SAMPLES
#216Loop-mediated isothermal amplification (LAMP) based assay for detecting microbes
#217METHOD FOR INHIBITING INFECTION AND ACTIVATION OF VIRUS
#218Methods and Systems for the Detection of Microorganisms Using Infectious Agents
#219SIMPLE METHOD FOR DETECTING NUCLEIC ACID SEQUENCE, ETC.
#220Devices and Methods for Collecting Gastrointestinal Samples
#221Signaling Pathway of Cannabidiol (CBD) for Prevention and Treatment of COVID-19
#222METHODS AND SYSTEMS FOR DETERMINING VIRUSES IN BIOLOGICAL SAMPLES USING A SINGLE ROUND BASED POOLING
#223Device and method for real-time detection of aeropathogens
#224METHODS AND SYSTEMS FOR CAPTURING BIOLOGICAL SAMPLES FROM A HEPA FILTER ON AN AIRCRAFT
#225SYSTEMS AND METHODS FOR COLLECTING A BIOLOGICAL SAMPLE FROM A PASSENGER CABIN
#226USE OF BIOLOGICAL SAMPLE REPRESENTATIVE OF A PASSENGER CABIN ON AN AIRCRAFT TO IDENTIFY ALL KNOWN MICROORGANISMS AND NON-DESCRIBED EMERGING PATHOGENS
#227Systems and processes for distinguishing pathogenic and non-pathogenic sequences from specimens
#228METHOD AND KIT FOR DETECTING INFLUENZA VIRUS, AND METHOD FOR DIAGNOSING INFLUENZA VIRUS INFECTION
#229BIOMARKERS, AND USES IN TREATMENT OF VIRAL INFECTIONS, INFLAMMATIONS, OR CANCER
#230Use of pooled samples to optimise the efficiency and utility of a rapid, lab-free point-of-care test
#231CHARACTERIZATION OF IMPURITIES IN ADENO-ASSOCIATED VIRUS (AAV) SAMPLES AND FORMULATION COMPOSITIONS TO STABILIZE AAV
#232Oligonucleotide-Templated Photoreduction Fluorogenic Probe Pairs and Their Use in Quantitative Detection of Target RNA Sequences
#233SYSTEMS AND METHODS FOR ULTRA-SPECIFIC AND ULTRA-SENSITIVE NUCLEIC ACID DETECTION
#234Method and devices for detecting viruses and bacterial pathogens
#235METHODS TO QUANTIFY VIRUS FROM WASTEWATER
#236DETECTION OF PATHOGENS IN WASTEWATER
#237Methods and compositions for influenza a virus subtyping
#238SIGNATURE FOR DIAGNOSIS OF BACTERIAL VS VIRAL INFECTIONS
#239VIRUS DETECTION IN WASTEWATER
#240ASYMMETRIC NANOPORE MEMBRANE (ANM) FILTRATION FOR HIGH-EFFICIENCY VIRUS ENRICHMENT AND PURIFICATION
#241Attb cell line, transgenic cell lines derived therefrom, and methods of making the same
#242Toilet Wastewater Collection and Testing
#243AAV-based conditional expression system
#244METHODS OF DETECTING NUCLEIC ACID BARCODES
#245METHOD, SYSTEM AND APPARATUS FOR BLOOD PROCESSING UNIT
#246METHODS FOR ASSESSING VIRAL CLEARANCE
#247Methods and compositions for pathogen detection in plants
#248Pooled testing methods using compressed sensing for increasing the throughput and reliability of tests for the detection of defective units in a population
#249IMMUNOASSAY FOR SARS-CoV-2 ANTIBODIES
#250METHOD FOR DETECTING AND QUANTIFYING LATENT RETROVIRAL RNA SPECIES
#251CO-BINDER ASSISTED ASSAY METHODS
#252PARALLELIZED SAMPLE PROCESSING AND LIBRARY PREP
#253METHOD
#254Infectious disease screening device
#255Blood cell lysis reagent
#256COMPOSITIONS AND METHODS FOR INDUCING BIOLOGICAL MIMICRY IN A MAMMAL FOR THE PREVENTION AND/OR TREATMENT OF COVID-19 AND OTHER DISEASES
#257Systems and methods for analyte testing and laboratory oversight
#258COMPOSITIONS AND METHODS FOR DETECTING VIRAL NUCLEIC ACIDS
#259MULTIPHASE NUCLEIC ACID AMPLIFICATION
#260Compositions and methods for internal controls of microvesicle isolations
#261BACTERIOPHAGE-BASED SERS-ACTIVE GOLD NANOHALO STRUCTURE AND MANUFACTURING METHOD THEREFOR
#262Infectious disease screening system
#263METHOD AND A KIT FOR DETECTING PATHOGENS
#264Saliva-based molecular testing for SARS-CoV-2
#265Systems and methods for multi-analysis
#266Infectious disease screening system
#267METHODS FOR DIAGNOSING INFECTIOUS DISEASE AND DETERMINING HLA STATUS USING IMMUNE REPERTOIRE SEQUENCING
#268METHODS AND COMPOSITIONS FOR PATHOGEN DETECTION IN PLANTS
#269BREAKABLE SAMPLE COLLECTION SWAB
#270PLASMONIC META-SURFACE BASED MOLECULAR SENSORS AND METHODS FOR MAKING AND USING THEM
#271SURVEILLANCE METHOD TO SCREEN ASYMPTOMATIC ESSENTIAL WORKERS FOR EXHALATION OF SARS-COV-2
#272Test to distinguish viral-only from bacterial infection or viral/bacterial coinfection using a respiratory swab
#273Methods and reagents for nucleic acids detection
#274PAPER-BASED COLORIMETRIC COVID-19/SARS-COV-2 TEST
#275RT-qPCR Molecular Detection and Diagnosis of 2019 Novel Coronavirus
#276RT-qPCR molecular detection and diagnosis
#277METHODS FOR MEASURING THE TITER AND POTENCY OF VIRAL VECTOR PARTICLES
#278PHOTOOXIDATIVE INACTIVATION OF PATHOGENS INCLUDING SARS-CoV-2
#279VIRAL TESTING IN SALIVA
#280METHOD OF QUANTITATIVE MEASUREMENT OF PARTICLE CONTENT USING HYDRATED STATE IMAGING
#281Infectious Microbe Detection Method and Apparatus
#282METHOD FOR MEASURING THE INFECTIVITY OF REPLICATION DEFECTIVE VIRAL VECTORS AND VIRUSES
#283Cure to new viruses and other diseases that do not have current cure
#284Reverse peptide vaccine
#285METHOD AND DEVICE FOR DETECTIONING AND MONITORING THE PRESENCE, DEVELOPMENT AND PROPAGATION OF INFECTIOUS AGENTS, IN PARTICULAR BACTERIA AND VIRUSES
#286DOWNLOADABLE SOFTWARE APPLICATION FOR GUIDING A RAPID TEST
#287Polynucleotides for amplification and detection of SARS-CoV-2
#288Methods of preventing and treating COVID-19 infection with probiotics
#289ASSAYS FOR THE DETECTION OF AAV NEUTRALIZING ANTIBODIES
#290Mitochondrial nucleic acid depletion and detection
#291METHODS FOR QUANTITATIVE AMPLIFICATION
#292SINDBIS CONTROL VIRUS
#293Liquid flourescent dye concentrate for flow cytometry evaluation of virus-size particles and related products and methods
#294Humanized dipeptidyl-peptidase IV (DPP4) animals
#295SYSTEMS AND METHODS OF SPECTROPHOTOMETRY FOR THE DETERMINATION OF GENOME CONTENT, CAPSID CONTENT AND FULL/EMPTY RATIOS OF ADENO-ASSOCIATED VIRUS PARTICLES
#296METHOD FOR DISCRIMINATING BETWEEN LIVE AND DEAD MICROBES IN A SAMPLE
#297Hydrophobic interaction chromatography for viral clearance
#298Reagent and method for fluorescence quantitative real-time PCR detection of RCL
#299Semiconductor structure and manufacturing method thereof
#300Genetically engineered foot and mouth disease virus and related proteins, polynucleotides, compositions, methods and systems